AW
GOSS icon

Alaethes Wealth’s Gossamer Bio GOSS Stock Holding History

Alaethes Wealth’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-750
Closed -$7K – 183
2022
Q1 		$7K Buy
+750
New +$7.23K ﹤0.01% 244
2021
Q4 		– Sell
-750
Closed -$9K – 288
2021
Q3 		$9K Hold
750
– – 0.01% 195
2021
Q2 		$6K Buy
+750
New +$6.5K ﹤0.01% 214

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alaethes Wealth's GOSS Position: Q2 2022 in Review

Alaethes Wealth sold out of Gossamer Bio (GOSS) in Q2 2022, closing a stake of 750 shares — an estimated $7K sold.

Alaethes Wealth first reported a position in GOSS in Q2 2021 and held it in 3 quarters. The position peaked at $9K in Q3 2021. 129 funds tracked by Wall St. Rank hold GOSS as of Q2 2022.

  • Alaethes Wealth reported no remaining Gossamer Bio position as of Q2 2022 after selling out during the quarter.
  • Alaethes Wealth sold 750 Gossamer Bio shares in Q2 2022, an estimated $7K.
  • Alaethes Wealth first reported a position in Gossamer Bio in Q2 2021 and held it in 3 quarters.
  • Alaethes Wealth's Gossamer Bio position peaked at $9K in Q3 2021.
  • 129 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2022.

Based on Alaethes Wealth's 13F filing for Q2 2022, filed 16 Aug 2022.